Skip to main content

Advertisement

SpringerLink
Log in

Unintentional Weight Loss as a Marker of Malignancy Across Body Weight Categories

  • Obesity and Diet (G. Rao, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Weight loss has long been known to be associated with multiple chronic conditions, including heart failure, COPD, depression, and cancer. Recent reports have suggested that unintentional weight loss (UWL) could be leveraged as an early marker of malignancy. Most studies use standardized cutoff values of ≥5% weight loss to define UWL; however, this threshold has not been validated in different body weight classifications (underweight, overweight, etc.). The purpose of this review was to describe the association between a patient’s weight category, the severity of UWL prior to cancer diagnosis, cancer stage at diagnosis, and cancer-specific mortality.

Recent Findings

Obesity has been identified as a risk factor for many malignancies. Current data are conflicting about whether patients with obesity are more or less likely to experience UWL prior to diagnosis of a malignancy. Similarly, data analyzing the association between baseline BMI and cancer stage at diagnosis or cancer-specific mortality are mixed. UWL has been associated with an increased risk of all-cause mortality, independent of baseline BMI. Unfortunately, reliable body weight measurements are infrequently obtained, decreasing the likelihood that UWL would be detected clinically.

Summary

Weight loss, when unintentional, is a serious condition which requires prompt clinical evaluation. Future studies are needed to objectively quantify UWL among patients with varying baseline BMI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118:1752–70.

    CAS  PubMed  Google Scholar 

  2. Eckel RH, Kahn SE, Ferrannini E, Goldfine AB, Nathan DM, Schwartz MW, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab. 2011;96:1654–63. https://doi.org/10.1210/jc.2011-0585.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Brown JD, Buscemi J, Milsom V, Malcolm R, O’Neil PM. Effects on cardiovascular risk factors of weight losses limited to 5–10 %. Transl Behav Med. 2016;6(3):339–46.

    PubMed  Google Scholar 

  4. Wilding JPH. The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract. 2014;68:682–91. https://doi.org/10.1111/ijcp.12384.

    Article  CAS  PubMed  Google Scholar 

  5. Anker SD, Negassa A, Coats AJS, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet (London, England). 2003;361:1077–83.

    CAS  Google Scholar 

  6. Wong CJ. Involuntary weight loss. Med Clin North Am. 2014;98:625–43. https://doi.org/10.1016/j.mcna.2014.01.012.

    Article  PubMed  Google Scholar 

  7. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J. 2002;20:539–44. https://doi.org/10.1183/09031936.02.00532002.

    Article  CAS  PubMed  Google Scholar 

  8. Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129:1708–17. https://doi.org/10.1002/ijc.25794.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41:1706–18. https://doi.org/10.1093/ije/dys176.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomark Prev. 2013;22:1395–408. https://doi.org/10.1158/1055-9965.EPI-13-0042.

    Article  Google Scholar 

  11. Wang F, Xu Y. Body mass index and risk of renal cell cancer: a dose–response meta-analysis of published cohort studies. Int J Cancer. 2014;135:1673–86. https://doi.org/10.1002/ijc.28813.

    Article  CAS  PubMed  Google Scholar 

  12. Campbell PT, Newton CC, Freedman ND, Koshiol J, Alavanja MC, Beane Freeman LE, et al. body mass index, waist circumference, diabetes, and risk of liver cancer for U.S. adults. Cancer Res. 2016;76:6076–83. https://doi.org/10.1158/0008-5472.CAN-16-0787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lee KR, Seo MH, Do Han K, Jung J, Hwang IC. Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults. Br J Cancer. 2018;119:1018–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Freisling H, Arnold M, Soerjomataram I, O’Doherty MG, Ordóñez-Mena JM, Bamia C, et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe. Br J Cancer. 2017;116:1486–97.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, et al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res. 2013;33:171–9.

    CAS  PubMed  Google Scholar 

  16. Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36–46.

    PubMed  Google Scholar 

  17. Theologides A. Weight Loss in Cancer Patients. CA Cancer J Clin. 1977;27:205–8.

    CAS  PubMed  Google Scholar 

  18. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69:491–7.

    CAS  PubMed  Google Scholar 

  19. Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, et al. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol Off J Eur Soc Med Oncol. 2014;25:1635–42.

    CAS  Google Scholar 

  20. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.

    PubMed  Google Scholar 

  21. Marton KI, Sox HC Jr, Krupp J. Involuntary weight loss: diagnostic and prognostic significance. Ann Intern Med. 1981;95:568–74. https://doi.org/10.7326/0003-4819-95-5-568.

    Article  CAS  PubMed  Google Scholar 

  22. Rabinovitz M, Pitlik SD, Leifer M, Garty M, Rosenfeld JB. Unintentional weight loss: a retrospective analysis of 154 cases. Arch Intern Med. 1986;146:186–7. https://doi.org/10.1001/archinte.1986.00360130224029.

    Article  CAS  PubMed  Google Scholar 

  23. Lankisch PG, Gerzmann M, Gerzmann JF, Lehnick D. Unintentional weight loss: diagnosis and prognosis. The first prospective follow-up study from a secondary referral centre. J Intern Med. 2001;249(1):41–6.

    CAS  PubMed  Google Scholar 

  24. Bilbao-Garay J, Barba R, Losa-García JE, Martín H. García de Casasola G, Castilla V, et al. Assessing clinical probability of organic disease in patients with involuntary weight loss: a simple score. Eur J Intern Med. 2002;13(4):240–5.

    CAS  PubMed  Google Scholar 

  25. Metalidis C, Knockaert DC, Bobbaers H, Vanderschueren S. Involuntary weight loss. Does a negative baseline evaluation provide adequate reassurance? Eur J Intern Med. 2008;19(5):345–9.

    PubMed  Google Scholar 

  26. Wu JM, Lin MH, Peng LN, Chen LK, Hwang SJ. Evaluating diagnostic strategy of older patients with unexplained unintentional body weight loss: a hospital-based study. Arch Gerontol Geriatr. 2011;53(1):e51–4.

    PubMed  Google Scholar 

  27. Chen SP, Peng LN, Lin MH, Lai HY, Hwang SJ, Chen LK. Evaluating probability of cancer among older people with unexplained, unintentional weight loss. Arch Gerontol Geriatr. 2010;50(Suppl 1):S27–9.

    PubMed  Google Scholar 

  28. • Hue JJ, Markt SC, Rao G, Winter JM. Patient-centered weight tracking as an early cancer detection strategy. J Cancer Prev. 2020;25:1–8 In this paper, Hue et al. reported the results of a weekly patient-centered weight tracking feasibility study. Of patients enrolled, 90% recorded at least one weight, and 74% of all possible weights were recorded. Importantly, 4% of the cohort experienced unintentional weight loss ≥5% in real time and underwent prompt clinical evaluation.

    Google Scholar 

  29. •• Hue JJ, Sugumar K, Kyasaram R, Shanahan J, Lyons J, Ocuin L, et al. Weight loss as an untapped early detection marker in pancreatic and periampullary cancer. Ann Surg Oncol. 2021. Hue et al. utilized clinically recorded patient weights and determine that 75% of patients diagnosed with pancreatic cancer experienced weight loss ≥5% in the year preceding their cancer diagnosis. Weight loss was common in both early- and late-stage diseases. Importantly, less than 1% of patients gained ≥5% weight before diagnosis.

  30. Yuan C, Babic A, Khalaf N, Nowak JA, Brais LK, Rubinson DA, et al. Diabetes, weight change, and pancreatic cancer risk. JAMA Oncol. 2020;6:e202948.

    PubMed  PubMed Central  Google Scholar 

  31. Nicholson BD, Hamilton W, O’Sullivan J, Aveyard P, Hobbs FR. Weight loss as a predictor of cancer in primary care: a systematic review and meta-analysis. Br J Gen Pract J R Coll Gen Pract. 2018;68:e311–22.

    Google Scholar 

  32. Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng KK, Marshall T. The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study. BMC Med. 2009;7:17.

    PubMed  PubMed Central  Google Scholar 

  33. Shen S, Araujo JL, Altorki NK, Sonett JR, Rodriguez A, Sungur-Stasik K, et al. Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients. Dis Esophagus. 2017;30:1–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Sahin C, Omar M, Tunca H, Kalemci S, Ozseker B, Akbaba G, et al. Weight loss at the time of diagnosis is not associated with prognosis in patients with advanced-stage non-small cell lung cancer. J BUON. 2015;20:1576–84.

    PubMed  Google Scholar 

  35. Olson SH, Xu Y, Herzog K, Saldia A, Defilippis EM, Li P, et al. Weight loss, diabetes, fatigue, and depression preceding pancreatic cancer. Pancreas. 2016;45(7):986–91.

    PubMed  PubMed Central  Google Scholar 

  36. Nicholson BD, Aveyard P, Price SJ, Hobbs FR, Koshiaris C, Hamilton W. Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study. BMJ. 2020;370:m2651.

    PubMed  PubMed Central  Google Scholar 

  37. Turicchi J, O’Driscoll R, Horgan G, Duarte C, Palmeira AL, Larsen SC, et al. Weekly, seasonal and holiday body weight fluctuation patterns among individuals engaged in a European multi-centre behavioural weight loss maintenance intervention. PLoS One. 2020;15:e0232152. https://doi.org/10.1371/journal.pone.0232152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wallace JI, Schwartz RS. Epidemiology of weight loss in humans with special reference to wasting in the elderly. Int J Cardiol. 2002;85:15–21. https://doi.org/10.1016/S0167-5273(02)00246-2.

    Article  PubMed  Google Scholar 

  39. Nicholson BD, Hamilton W, Koshiaris C, Oke JL, Hobbs FDR, Aveyard P. The association between unexpected weight loss and cancer diagnosis in primary care: a matched cohort analysis of 65,000 presentations. Br J Cancer. 2020;122:1848–56.

    PubMed  PubMed Central  Google Scholar 

  40. Hernández JL, Riancho JA, Matorras P, González-Macías J. Clinical evaluation for cancer in patients with involuntary weight loss without specific symptoms. Am J Med. 2003;114:631–7.

    PubMed  Google Scholar 

  41. Baicus C, Ionescu R, Tanasescu C. Does this patient have cancer? The assessment of age, anemia, and erythrocyte sedimentation rate in cancer as a cause of weight loss. A retrospective study based on a secondary care university hospital in Romania. Eur J Intern Med. 2006;17:28–31.

    PubMed  Google Scholar 

  42. Perera LAM, Chopra A, Shaw AL. Approach to patients with unintentional weight loss. Med Clin North Am. 2021;105:175–86. https://doi.org/10.1016/j.mcna.2020.08.019.

    Article  PubMed  Google Scholar 

  43. Thompson MP, Morris LK. Unexplained weight loss in the ambulatory elderly. J Am Geriatr Soc. 1991;39(5):497–500.

    CAS  PubMed  Google Scholar 

  44. Goh Y, Dan YY, Chua W, Jagmohan P, Lee JK-T, Thian YL. Diagnostic utility of whole body CT scanning in patients with unexplained weight loss. PLoS One. 2018;13:e0200686. https://doi.org/10.1371/journal.pone.0200686.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Wannamethee SG, Shaper AG, Lennon L. Reasons for intentional weight loss, unintentional weight loss, and mortality in older men. Arch Intern Med. 2005;165:1035–40.

    PubMed  Google Scholar 

  46. De Stefani C, Pietraroia PS, Fernandes-silva MM. Observational evidence for unintentional weight loss in all-cause mortality and major cardiovascular events : a systematic review and meta-analysis. Sci Report. 2018;8:15447.

    Google Scholar 

  47. Harrington M, Gibson S, Cottrell RC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nutr Res Rev. 2009;22:93–108.

    PubMed  Google Scholar 

  48. Barazzoni R, Sulz I, Schindler K, Bischoff SC, Gortan G, Hiesmayr M. Original article. A negative impact of recent weight loss on in-hospital mortality is not modified by overweight and obesity. Clin Nutr. 2020;39:2510–6. https://doi.org/10.1016/j.clnu.2019.11.007.

    Article  PubMed  Google Scholar 

  49. van Zutphen M, Geelen A, Boshuizen HC, Winkels RM, Geijsen AJMR, Wesselink E, et al. Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease. Support Care Cancer. 2019;27:1541–9. https://doi.org/10.1007/s00520-018-4560-z.

    Article  PubMed  Google Scholar 

  50. Morel H, Raynard B, d’Arlhac M, Hauss P-A, Lecuyer E, Oliviero G, et al. Prediagnosis weight loss, a stronger factor than BMI, to predict survival in patients with lung cancer. Lung Cancer. 2018;126:55–63. https://doi.org/10.1016/j.lungcan.2018.07.005.

    Article  PubMed  Google Scholar 

  51. Hendifar AE, Petzel MQB, Zimmers TA, Denlinger CS, Matrisian LM, Picozzi VJ, et al. Pancreas cancer-associated weight loss. Oncologist. 2019;24:691–701.

    PubMed  Google Scholar 

  52. Gannavarapu BS, Lau SKM, Carter K, Cannon NA, Gao A, Ahn C, et al. Prevalence and survival impact of pretreatment cancer-associated weight loss: a tool for guiding early palliative care. J Oncol Pract. 2018;14:e238–50. https://doi.org/10.1200/JOP.2017.025221.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21:73–9. https://doi.org/10.1016/S1470-2045(19)30595-9.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Lau SKM, Gannavarapu BS, Carter K, Gao A, Ahn C, Meyer JJ, et al. Impact of socioeconomic status on pretreatment weight loss and survival in non-small-cell lung cancer. J Oncol Pract. 2018;14:e211–20. https://doi.org/10.1200/JOP.2017.025239.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Elsafi SH, Alqahtani NI, Zakary NY, Al Zahrani EM. The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings. Clin Exp Gastroenterol. 2015;8:279–84. https://doi.org/10.2147/CEG.S86419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, et al. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. Br J Cancer. 2016;114:103–9. https://doi.org/10.1038/bjc.2015.424.

    Article  CAS  PubMed  Google Scholar 

  57. Sahyoun NR, Serdula MK, Galuska DA, Zhang XL, Pamuk ER. The epidemiology of recent involuntary weight loss in the United States population. J Nutr Health Aging. 2004;8:510–7.

    CAS  PubMed  Google Scholar 

  58. Argilés JM, López-Soriano FJ, Busquets S. Mediators of cachexia in cancer patients. Nutrition. 2019;66:11–5. https://doi.org/10.1016/j.nut.2019.03.012.

    Article  CAS  PubMed  Google Scholar 

  59. Vazeille C, Jouinot A, Durand J-P, Neveux N, Boudou-Rouquette P, Huillard O, et al. Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy. Am J Clin Nutr. 2017;105:1139–47.

    CAS  PubMed  Google Scholar 

  60. Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, et al. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle. 2015;6:95–8. https://doi.org/10.1002/jcsm.12014.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer. 2003;89:519–23.

    CAS  PubMed  Google Scholar 

  62. Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, Bain CJ, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut. 2008;57:173–80.

    CAS  PubMed  Google Scholar 

  63. •• Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (London, England). 2008;371:569–78 Renehan et al. performed a comprehensive review and meta-analysis detailing the link between obesity and cancer.

    Google Scholar 

  64. Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48:2137–45.

    PubMed  Google Scholar 

  65. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007;96:1457–61. https://doi.org/10.1038/sj.bjc.6603703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, et al. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One. 2013;8:e53916.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer — viewpoint of the IARC working group. N Engl J Med. 2016;375:794–8. https://doi.org/10.1056/NEJMsr1606602.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA. Obesity, inflammation, and cancer. Annu Rev Pathol. 2016;11:421–49.

    CAS  PubMed  Google Scholar 

  69. Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016;29:77–89. https://doi.org/10.1016/j.coph.2016.07.005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Cleary MP, Grossmann ME. Minireview: obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150:2537–42. https://doi.org/10.1210/en.2009-0070.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Leitzmann MF, Koebnick C, Danforth KN, Brinton LA, Moore SC, Hollenbeck AR, et al. Body mass index and risk of ovarian cancer. Cancer. 2009;115:812–22. https://doi.org/10.1002/cncr.24086.

    Article  PubMed  Google Scholar 

  72. Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34:4225–30. https://doi.org/10.1200/JCO.2016.69.4638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296:193–201. https://doi.org/10.1001/jama.296.2.193.

    Article  CAS  PubMed  Google Scholar 

  74. • Tee MC, Cao Y, Warnock GL, Hu FB, Chavarro JE. Effect of bariatric surgery on oncologic outcomes: a systematic review and meta-analysis. Surg Endosc. 2013;27:4449–56. https://doi.org/10.1007/s00464-013-3127-9This analysis by Tee et al. emphasized the importance of the intentionality of weight loss. In patients with obesity who underwent bariatric surgery, the risk of malignancy was reduced as compared to control patients with obesity.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Alshamsan BI, Suleman K, Agha N, Abdelgawad MI, Alzahrani MJ, Al-Tweigeri T, et al. Association between obesity and the clinical stage of newly diagnosed breast cancer: experience with 2212 patients. J Clin Oncol. 2020;38(15_suppl):e12602. https://doi.org/10.1200/JCO.2020.38.15_suppl.e12602.

    Article  Google Scholar 

  76. Ayoub NM, Yaghan RJ, Abdo NM, Matalka II, Akhu-Zaheya LM, Al-Mohtaseb AH. Impact of obesity on clinicopathologic characteristics and disease prognosis in pre- and postmenopausal breast cancer patients: a retrospective institutional study. J Obes. 2019;2019:3820759–11. https://doi.org/10.1155/2019/3820759.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Chagpar AB, McMasters KM, Saul J, Nurko J, Martin RCG 2nd, Scoggins CR, et al. Body mass index influences palpability but not stage of breast cancer at diagnosis. Am Surg. 2007;73:555–60 discussion 560.

    PubMed  Google Scholar 

  78. Neumann K, Mahmud SM, McKay A, Park J, Metcalfe J, Hochman DJ. Is obesity associated with advanced stage or grade of colon cancer? Can J Surg. 2015;58:140–2. https://doi.org/10.1503/cjs.004414.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Djajadiningrat RS, van Werkhoven E, Horenblas S. Penile cancer stage, survival and body mass index. Urol Int. 2015;94:220–4.

    PubMed  Google Scholar 

  80. Kocoglu H, Dogan H, Oguz B, Ocak Serin S, Okuturlar Y, Gunaldi M, et al. Comparison of survival rates, tumor stages, and localization in between obese and nonobese patients with gastric cancer. Gastroenterol Res Pract. 2016;2016:9382750–5. https://doi.org/10.1155/2016/9382750.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Dieringer P, Klass EM, Caine B, Smith-Gagen J. Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study. J Cancer Res Clin Oncol. 2015;141:93–8.

    PubMed  Google Scholar 

  82. Schlesinger S, Siegert S, Koch M, Walter J, Heits N, Hinz S, et al. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis. Cancer Causes Control. 2014;25:1407–18.

    PubMed  Google Scholar 

  83. Amptoulach S, Gross G, Kalaitzakis E. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res. 2015;199:378–85.

    PubMed  Google Scholar 

  84. Brunner AM, Sadrzadeh H, Feng Y, Drapkin BJ, Ballen KK, Attar EC, et al. Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemia. Am J Hematol. 2013;88:642–6.

    PubMed  PubMed Central  Google Scholar 

  85. Tsang NM, Pai PC, Chuang CC, Chuang WC, Tseng CK, Chang KP, et al. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med. 2016;5:665–75. https://doi.org/10.1002/cam4.634.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Cancer Inst. 2013;105:1862–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 2006;68:741–6.

    PubMed  Google Scholar 

  88. • Lennon H, Sperrin M, Badrick E, Renehan AG. The obesity paradox in cancer: a review. Curr Oncol Rep. 2016;18:56 In this review paper, Lennon et al. summarized the current literature focused on the obesity paradox in patients with cancer and make note of important biases and confounding factors in past studies.

    PubMed  PubMed Central  Google Scholar 

  89. Lee DH, Giovannucci EL. The obesity paradox in cancer: epidemiologic insights and perspectives. Curr Nutr Rep. 2019;8:175–81.

    PubMed  Google Scholar 

  90. Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol Off J Eur Soc Med Oncol. 2014;25:1901–14.

    CAS  Google Scholar 

  91. Protani MM, Nagle CM, Webb PM. Obesity and ovarian cancer survival: a systematic review and meta-analysis. Cancer Prev Res (Phila). 2012;5:901–10.

    Google Scholar 

  92. Yoon HH, Lewis MA, Shi Q, Khan M, Cassivi SD, Diasio RB, et al. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29:4561–7.

    Google Scholar 

  93. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women’s Health Study. Cancer. 1995;76:275–83.

    CAS  PubMed  Google Scholar 

  94. •• Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38 Using a prospectively maintained patient cohort of over 900,000 people, Calle et al. demonstrated that patients with obesity had a greater cancer-specific mortality rate relative to normal-weight individuals. The authors estimated that between 14 and 20% of cancer deaths in the USA were due to obesity.

    PubMed  Google Scholar 

  95. Tan BHL, Birdsell LA, Martin L, Baracos VE, Fearon KCH. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973–9. https://doi.org/10.1158/1078-0432.CCR-09-1525.

    Article  CAS  PubMed  Google Scholar 

  96. Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629–35.

    PubMed  Google Scholar 

  97. Navarro WH, Loberiza FRJ, Bajorunaite R, van Besien K, Vose JM, Lazarus HM, et al. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2006;12:541–51.

    Google Scholar 

  98. Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer. 2012;48:853–64.

    PubMed  Google Scholar 

  99. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11–48. https://doi.org/10.1016/j.clnu.2016.07.015.

    Article  PubMed  Google Scholar 

  100. Wu S, Liu J, Wang X, Li M, Gan Y, Tang Y. Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies. Cancer Causes Control. 2014;25:1489–502.

    PubMed  Google Scholar 

  101. Linde JA, Jeffery RW, French SA, Pronk NP, Boyle RG. Self-weighing in weight gain prevention and weight loss trials. Ann Behav Med. 2005;30:210–6.

    PubMed  Google Scholar 

  102. Fontaine KR, Faith MS, Allison DB, Cheskin LJ. Body weight and health care among women in the general population. Arch Fam Med. 1998;7:381–4.

    CAS  PubMed  Google Scholar 

  103. El-Kareh R, Pazo V, Wright A, Schiff GD. Losing weights: failure to recognise and act on weight loss documented in an electronic health record. J Innov Heal Informatics. 2015;22(3):316–22.

    Google Scholar 

  104. • Nicholson BD, Aveyard P, Bankhead CR, Hamilton W, FDR H, Lay-Flurrie S. Determinants and extent of weight recording in UK primary care: an analysis of 5 million adults’ electronic health records from 2000 to 2017. BMC Med. 2019;17:222. https://doi.org/10.1186/s12916-019-1446-yNicholson et al. detailed weight measurements in 4.9 million patients and identified several obstacles to the widespread use of rigorous weight tracking for diagnostic purposes. Only one third of patients had a weight recorded, and serial weights were on average almost 2 years apart.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, 44106, USA

    Jonathan J. Hue & Jordan M. Winter

  2. Department of Family Medicine and Community Health, Case Western Reserve University, Cleveland, OH, USA

    Kelsey Ufholz

  3. Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA

    Sarah C. Markt

Authors
  1. Jonathan J. Hue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelsey Ufholz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jordan M. Winter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah C. Markt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan J. Hue.

Ethics declarations

Conflict of Interest

Jonathan Hue, Kelsey Ufholz, Jordan Winter, and Sarah Markt declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Obesity and Diet

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hue, J.J., Ufholz, K., Winter, J.M. et al. Unintentional Weight Loss as a Marker of Malignancy Across Body Weight Categories. Curr Cardiovasc Risk Rep 15, 10 (2021). https://doi.org/10.1007/s12170-021-00674-8

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12170-021-00674-8

Keywords

Search

Navigation